In an interaction with Thiruamuthan, Correspondent at India Pharma Outlook, Vikram Aditya Sehgal, Director – Finance, Centrient India, discusses India’s PLI-backed API projects are strengthening domestic manufacturing and reducing import dependence,

As demand grows for microbiome-safe and skin-type-specific hygiene products, how are Indian brands rethinking personalization across formulation, packaging, and user engagement strategies

Arushi Jain, a corporate growth strategist in the pharmaceutical sector, brings over a decade of cross-functional experience. She specializes in operational excellence, risk advisory, and scaling healthcare ventures. With expertise spanning internal

In an interaction with India Pharma Outlook, Dr. Mohan Keshavamurthy, Principal Director – Renal Sciences at Fortis Healthcare, discusses how robotic surgery is revolutionizing kidney transplants in India by improving surgical precision, reducing war

In an exclusive interaction with India Pharma Outlook, Nitin Stephen Abel, Senior Director, Terumo Interventional Systems, Terumo India, discusses how India’s shift toward outpatient surgeries is driving medical device manufacturers to reengineer min

In an exclusive interaction with India Pharma Outlook, Dr. Pankaj Gupta, Senior Medical Director at Pfizer India, sheds light on the escalating threat of antimicrobial resistance in India’s ICUs. He discusses evo